Health TScan Therapeutics Reports Promising Findings from ALLOHA Trial TScan Therapeutics has announced encouraging results from its ALLOHA Phase 1 clinical trial, focusing on the treatment of hematological malignancies. The latest data indicates... Editorial3 hours ago